Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
35.25
+0.37 (1.06%)
At close: Dec 3, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $12.52 billion as of January 6, 2026. Its market cap has increased by 24.92% in one year.
Market Cap
12.52B
Enterprise Value
13.88B
Revenue
2.96B
Ranking
n/a
PE Ratio
9,073.53
Stock Price
$35.25
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 12.52B, an increase of 1,788.00%. That is a compound annual growth rate of 16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 12.52B | 0.31% |
| Dec 30, 2025 | 12.48B | 25.05% |
| Dec 30, 2024 | 9.98B | 9.75% |
| Dec 29, 2023 | 9.09B | 46.56% |
| Dec 30, 2022 | 6.20B | 1.41% |
| Dec 30, 2021 | 6.12B | 2.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |